Peficitinib: A New Hope for Rare Joint Tumors
Imagine a tough, benign tumor that grows in your joints and often comes back even after surgery. That's diffuse-type tenosynovial giant cell tumor (dTGCT) for you. Scientists are on a mission to find better drugs to treat this sneaky tumor. They've been looking at a signaling pathway called JAK/STAT